CLINICAL_TRIALS
trial_result
· 2015-01-06
Clinical Trial Update: Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients [Phase 3]
Summary
Macitentan was studied in a Phase 3 trial for treating digital ulcers in systemic sclerosis; results were posted January 6, 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Systemic Sclerosis, Ulcers | Phase 3 | Status: COMPLETED | Results posted: 2015-01-06